“Safety Assessment of Dose-Escalated 225Ac-PSMA-617 Radioligand Therapy in Patients With Advanced Metastatic Castration-Resistant Prostate Cancer Following Standard Treatment Failure”. Voprosy onkologii 71, no. 5 (November 5, 2025): OF-2520. Accessed October 14, 2026. https://voprosyonkologii.ru/index.php/journal/article/view/5-25-Safety-Assessment-of.